INFI-MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
INFI-MED
Largest movements
- Receivables within one year +€5,356
up €5,356 (+14.9%), from €35,985 to €41,341
- Deferred charges and accrued income +€5,000
up €5,000 (+72.2%), from €6,928 to €11,928
- Current investments -€1,047
down €1,047 (-26.8%), from €3,906 to €2,859
- Profit (loss) carried forward +€9,978
up €9,978 (+13.3%), from €74,789 to €84,768
- Trade debts -€1,186
down €1,186 (-91.1%), from €1,301 to €116
- Financial income +€15,927
new in 2025: €15,927
- Taxes +€7,378
up €7,378 (+158%), from €4,658 to €12,037
- Gross operating margin -€6,446
down €6,446 (-49.7%), from €12,967 to €6,521
- Other operating charges -€543
down €543 (-59.8%), from €907 to €364
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €81,619 | €90,928 | +€9,310 | +11.4% |
| Current assets | 29/58 | €81,619 | €90,928 | +€9,310 | +11.4% |
| Amounts receivable after more than one year | 29 | €34,800 | €34,800 | = | 0.0% |
| Other amounts receivable | 291 | €34,800 | €34,800 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €35,985 | €41,341 | +€5,356 | +14.9% |
| Other amounts receivable | 41 | €35,985 | €41,341 | +€5,356 | +14.9% |
| Current investments | 50/53 | €3,906 | €2,859 | -€1,047 | -26.8% |
| Deferred charges and accrued income | 490/1 | €6,928 | €11,928 | +€5,000 | +72.2% |
| Total equity and liabilities | 10/49 | €81,619 | €90,928 | +€9,310 | +11.4% |
| Equity | 10/15 | €74,790 | €84,769 | +€9,978 | +13.3% |
| Contributions | 10/11 | €1 | €1 | = | 0.0% |
| Capital | 10 | €1 | €1 | = | 0.0% |
| Issued capital | 100 | €1 | €1 | = | 0.0% |
| Profit (loss) carried forward | 14 | €74,789 | €84,768 | +€9,978 | +13.3% |
| Amounts payable | 17/49 | €6,828 | €6,160 | -€669 | -9.8% |
| Amounts payable within one year | 42/48 | €6,828 | €6,160 | -€669 | -9.8% |
| Trade debts | 44 | €1,301 | €116 | -€1,186 | -91.1% |
| Suppliers | 440/4 | €1,301 | €116 | -€1,186 | -91.1% |
| Taxes, remuneration and social security | 45 | €5,527 | €6,027 | +€500 | +9.0% |
| Taxes | 450/3 | €5,527 | €6,027 | +€500 | +9.0% |
| Other amounts payable | 47/48 | - | €17 | +€17 | |
| Non-recurring operating income | 76A | €817 | - | -€817 | |
| Other operating charges | 640/8 | €907 | €364 | -€543 | -59.8% |
| Gross operating margin | 9900 | €12,967 | €6,521 | -€6,446 | -49.7% |
| Operating profit (loss) | 9901 | €12,060 | €6,157 | -€5,903 | -48.9% |
| Financial income | 75/76B | - | €15,927 | +€15,927 | |
| Recurring financial income | 75 | - | €15,927 | +€15,927 | |
| Financial charges | 65/66B | €59 | €68 | +€9 | +15.4% |
| Recurring financial charges | 65 | €59 | €68 | +€9 | +15.4% |
| Profit (loss) for the period before taxes | 9903 | €12,001 | €22,015 | +€10,014 | +83.4% |
| Income taxes | 67/77 | €4,658 | €12,037 | +€7,378 | +158% |
| Profit (loss) for the period | 9904 | €7,342 | €9,978 | +€2,636 | +35.9% |
| Profit (loss) for the period to be appropriated | 9905 | €7,342 | €9,978 | +€2,636 | +35.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.